These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19362342)

  • 1. Knockdown of p21-activated kinase 6 inhibits prostate cancer growth and enhances chemosensitivity to docetaxel.
    Wen X; Li X; Liao B; Liu Y; Wu J; Yuan X; Ouyang B; Sun Q; Gao X
    Urology; 2009 Jun; 73(6):1407-11. PubMed ID: 19362342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation.
    Morikawa Y; Koike H; Sekine Y; Matsui H; Shibata Y; Ito K; Suzuki K
    Biochem Biophys Res Commun; 2012 Mar; 419(3):584-9. PubMed ID: 22387542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased PAK6 expression in prostate cancer and identification of PAK6 associated proteins.
    Kaur R; Yuan X; Lu ML; Balk SP
    Prostate; 2008 Oct; 68(14):1510-6. PubMed ID: 18642328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tumor growth and sensitization to chemotherapy by RNA interference targeting interleukin-6 in the androgen-independent human prostate cancer PC3 model.
    Sakai I; Miyake H; Terakawa T; Fujisawa M
    Cancer Sci; 2011 Apr; 102(4):769-75. PubMed ID: 21214673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo.
    Henry JY; Lu L; Adams M; Meyer B; Bartlett JB; Dalgleish AG; Galustian C
    Prostate; 2012 Jun; 72(8):856-67. PubMed ID: 21968939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin enhances the susceptibility of both androgen-dependent and -independent prostate carcinoma cells to docetaxel.
    Liu QJ; Xu XH; Shang DH; Tian Y; Lü WC; Zhang YH
    Chin Med J (Engl); 2010 Feb; 123(3):356-60. PubMed ID: 20193259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA‑328 directly targets p21‑activated protein kinase 6 inhibiting prostate cancer proliferation and enhancing docetaxel sensitivity.
    Liu C; Zhang L; Huang Y; Lu K; Tao T; Chen S; Zhang X; Guan H; Chen M; Xu B
    Mol Med Rep; 2015 Nov; 12(5):7389-95. PubMed ID: 26459798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressed tumour growth and enhanced chemosensitivity by RNA interference targeting Aurora-A in the PC3 human prostate cancer model.
    Kumano M; Miyake H; Terakawa T; Furukawa J; Fujisawa M
    BJU Int; 2010 Jul; 106(1):121-7. PubMed ID: 19912186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy.
    Sowery RD; Hadaschik BA; So AI; Zoubeidi A; Fazli L; Hurtado-Coll A; Gleave ME
    BJU Int; 2008 Aug; 102(3):389-97. PubMed ID: 18336596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer.
    Musende AG; Eberding A; Jia W; Ramsay E; Bally MB; Guns ET
    Prostate; 2010 Sep; 70(13):1437-47. PubMed ID: 20687217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of p21-activated kinase 6 (PAK6) increases radiosensitivity of prostate cancer cells.
    Zhang M; Siedow M; Saia G; Chakravarti A
    Prostate; 2010 Jun; 70(8):807-16. PubMed ID: 20054820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of PAK6 and PSMB4 expression in patients with localized prostate cancer treated with dose-escalation radiation therapy and androgen deprivation therapy.
    Zapatero A; Morente M; Nieto S; Martín de Vidales C; Lopez C; Adrados M; Arellano R; Artiga MJ; Garcia-Vicente F; Herranz LM; Leaman O
    Urol Oncol; 2014 Nov; 32(8):1327-32. PubMed ID: 24946957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling.
    Gan L; Wang J; Xu H; Yang X
    Prostate; 2011 Aug; 71(11):1158-66. PubMed ID: 21656826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The suppression of aurora-A/STK15/BTAK expression enhances chemosensitivity to docetaxel in human esophageal squamous cell carcinoma.
    Tanaka E; Hashimoto Y; Ito T; Kondo K; Higashiyama M; Tsunoda S; Ortiz C; Sakai Y; Inazawa J; Shimada Y
    Clin Cancer Res; 2007 Feb; 13(4):1331-40. PubMed ID: 17317845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of JNK-1 by small interfering RNA induces apoptotic signaling in PC-3 prostate cancer cells.
    Parra E
    Int J Mol Med; 2012 Oct; 30(4):923-30. PubMed ID: 22766602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3,3'-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
    Rahman KM; Banerjee S; Ali S; Ahmad A; Wang Z; Kong D; Sakr WA
    Cancer Res; 2009 May; 69(10):4468-75. PubMed ID: 19435906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cloning of human PAK6 cDNA, preparation of anti-PAK6 polyclonal antibody and PAK6 expression in prostate cancer].
    Han YJ; An ZW; Yang JX; Li J; Luo RC; Zhang HQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):827-30. PubMed ID: 17584649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of zinc finger protein X-linked inhibits prostate cancer cell proliferation and induces apoptosis by activating caspase-3 and caspase-9.
    Jiang H; Zhang L; Liu J; Chen Z; Na R; Ding G; Zhang H; Ding Q
    Cancer Gene Ther; 2012 Oct; 19(10):684-9. PubMed ID: 22898899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitor potentiates anticancer effect of docetaxel via modulation of Bcl-2 family proteins and tubulin in hormone refractory prostate cancer cells.
    Hwang JJ; Kim YS; Kim MJ; Kim DE; Jeong IG; Kim CS
    J Urol; 2010 Dec; 184(6):2557-64. PubMed ID: 21030039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.